# A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

> **NCT00605930** · NA · COMPLETED · sponsor: **University of Louisville** · enrollment: 20 (actual)

## Conditions studied

- Progressive Supranuclear Palsy

## Interventions

- **DIETARY_SUPPLEMENT:** Pyruvate, creatine, niacinamide
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00605930
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605930, "A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00605930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*